| Tag | Content |
|---|
EnhancerAtlas ID | HS139-51153 |
Organism | Homo sapiens |
Tissue/cell | Myotube |
Coordinate | chr7:94720880-94722910 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXC1 | MA0032.2 | chr7:94722649-94722660 | ATATTTACATA | - | 6.62 | | MSC | MA0665.1 | chr7:94721834-94721844 | AACAGCTGTT | + | 6.02 | | MSC | MA0665.1 | chr7:94721834-94721844 | AACAGCTGTT | - | 6.02 | | MYF6 | MA0667.1 | chr7:94721834-94721844 | AACAGCTGTT | + | 6.02 | | MYF6 | MA0667.1 | chr7:94721834-94721844 | AACAGCTGTT | - | 6.02 | | POU2F2 | MA0507.1 | chr7:94720990-94721003 | TTAATTTGCATTT | + | 6.25 | | SCRT1 | MA0743.1 | chr7:94721923-94721938 | AAGCACCTGTTGAGT | - | 6 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH07I095091 | chr7 | 94720829 | 94722333 |
|
Enhancer Sequence | CCTGACCTCA AGTGATCTGC CCGTCTTGGC CTCCCAAAGT GCTGGGATTA CAGGCGTGAG 60
CCACCATGAC CAGCCTTAAA TCTTTGTAGA TGAAAAATTA CTTATGTAAT TTAATTTGCA 120
TTTCTTTAGT TACTAGTAAG TTTGAATCTC TACCCCCTTC AATTTATGGC CCTTTGCAGT 180
TGTGGGGGCA GGGCATGTGT TGTTTATTCT ATGTAGGGGT GCTTATTTTA GTTTTGGCAT 240
TTGGTGCGTT AATAATGCTT TTTTTTTTTT TTCAAACTAA AGCTGTGTGG CAAGGAGAGA 300
AAAGCATGGT TTTTTAATTC ATGGACTTGT ATTTCGTTGT CACTTATGTA TTTCCTGTGT 360
GTCTTTGGGC CAACTGTCTG TCATCTGTGA GCCTGAAGTT GACTGACCTG CCAAAAAAGA 420
TGATTATGAG ATTTAAATGA GACACCTATC CCAGAAGAAT CACTCGATGG TAGCTGCACT 480
TCTCCTTTTC CTCACCTCCT CATTATCACC TACCTGTTAT TTCTCTCTTT AGGCATTTTT 540
GAACAGAATT GAAGGAAAAC GCCATTCAAG TCTGCTATTT GCCTGTAAAC AGAGTGGATA 600
CAATCTCACT GACCACCCAA TAGTCACTGT TAAAATCTTT TCAATTCTTA TGATGACAGC 660
TGATGGATAT ACTTTTACAT TATATTTAGT GAGAAAGGAG TGGAAAGAGA GCCAGCACTG 720
GAACAGGCAC AGCCATCAGA GGAGCAGCTT TTTCTTGTCT GTATCTTATA CTACACGCTT 780
TTTTTTTTTT TTTGATTAAA GACTAGTTCT CTGTGTTGCA TTTTTATGCC AACTTTAGCT 840
GCTGCCAGAA TCTTGGATGC CCTAAATACC AGTGCTTACA GTGGAAGCCA GCAGGGTGGA 900
CCAGACAGTG AAAAAGATTC CTTTGCTCAT GTTGTCAGCT TATCTGAAAT CTTGAACAGC 960
TGTTTGAATG AATGAATGAA GTACATATTA AAGGGAGTTA CAGAACTTCC AAAAGAACTG 1020
CTTTTATCAG GCAGACTCCC TGTAAGCACC TGTTGAGTAG ATCCTCTGTC AGGCACAATG 1080
CCAAATTTTG GAGATACAGT GGAAGTAAGA CACTAGTCCT GTGCTGAAGA TGGCAGATTT 1140
AAACAAGAAA ATAGCATTAA CAAATGAAAT GCGGCATATA AGTACGAAAG GACTACAGGT 1200
GTTCTAGACA AGAGGATAGT CATCTAATAT TGGAGGATAT TGTCATAGGA AAGTTCCAAG 1260
ATATTCAAGA AATTGAGACC TATAATTTGG AAGAGGTTTT GGTTTCTTCC AAAGTGAGAG 1320
AGTGAGGCTT AATTCTCTCC TGTATTAAAC TGTGTTGCTA TAATTGCTTT GTCTATGTCA 1380
GGGTGACTTG TAAGAAGCAA ATGGACATTT GAGTGCAACT ACACTTTTGT TTAAGACATA 1440
TGGCATATGT ATTTACCTTC CCGATATCAA TATGGCAGGT GGAGATGACA TGCCATGCCA 1500
ACAGGTTTTG GTAGACTTGA GTTCTTATAC ATGGGATGAT GTTTTGTTTT ATTTTGTTTT 1560
GTTTTTTTGG CTCGGGAGAG GACAGGCACC AACAGATAGA CTTTCTCAGG ATAGACCACC 1620
ATGACTAGAA TGCAAAACTG TAAAAGTGAC TGCTATATTT TAATCAGCAA ATCTGCCACA 1680
GTTGTGGGAC ATTAAAGCCC TAATTGACCC TACATCACCT AAAGATAGGT GCTGCACTCA 1740
AGGCTGCAAA GGGAGCCAAC CACTTTTATA TATTTACATA TTTAAATCCA TTCTCCAGCA 1800
ACAATTGAAA TACTTGTAAG CATTTTAATT CTTCCTGCCG GCTCTGTATT TCAACCTGAG 1860
GACCCAAATA ATACAATTTC ATCCACAACA GTAAAGCTAA TTACCCTTGA CTGTAGCATT 1920
TCTAATACAA TTTTATTTTA GCATTTCAAA ATACATTTGA AAAGTAAATT ATGAGTTCTT 1980
CCAAACTAGA TTCTCTACTT AGTCACATTA AAATGATCAA AAAATGGAAA 2030
|
